MedPath
HSA Approval

Lukakline Tablet 10 mg

SIN14154P

Lukakline Tablet 10 mg

Lukakline Tablet 10 mg

June 7, 2012

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

R03DC03

montelukast

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

Dr. Reddy's Laboratories Limited (FTO-III)

Active Ingredients

Montelukast sodium 10.4 mg eqv montelukast

10 mg

Montelukast

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lukakline Tablet 10 mg - HSA Approval | MedPath